Isatuximab in multiple myeloma.

Enrica Antonia Martino, Antonella Bruzzese, Enrico Iaccino, Francesco Mendicino, Selena Mimmi, Eugenio Lucia, Virginia Olivito, Antonino Neri, Fortunato Morabito, Ernesto Vigna, Massimo Gentile

Journal: Expert opinion on biological therapy 2023;23(4):315-318

PMID: 36943846

Full Text on Atypon View on PubMed

Abstract

Address: Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy.; Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro, Italy.; Scientific Directorate IRCCS of Reggio Emilia, EmiliaRomagna, Reggio Emilia, Italy.; Biotechnology Research Unit, AO of Cosenza, Cosenza, Italy.; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende, Italy.

DOI: 10.1080/14712598.2023.2193289

Link outs

Free resources

Medical:

https://medlineplus.gov/multiplemyeloma.html

Subscription / membership required

Full Text Sources:

https://www.tandfonline.com/doi/10.1080/14712598.2...

MeSH Terms: Humans, Multiple Myeloma, Antibodies, Monoclonal, Humanized, Antibodies, Monoclonal, Dexamethasone, Antineoplastic Combined Chemotherapy Protocols